新里程收盘下跌1.84%，滚动市盈率64.35倍，总市值72.15亿元

Group 1 - The core viewpoint of the articles highlights the financial performance and market position of New Mile Health Technology Group Co., Ltd, indicating a decline in revenue and net profit in the latest quarterly report [1][2] - As of the latest quarter, New Mile's stock price closed at 2.13 yuan, with a PE ratio of 64.35, significantly higher than the industry average of 43.29 [1][2] - The company has a total market capitalization of 7.215 billion yuan, ranking 33rd in the medical services industry based on PE ratio [1][2] Group 2 - The company's main business focuses on medical services and pharmaceutical production, with a core product line centered around the "Duyiwei" brand of traditional Chinese medicine [1] - The latest quarterly report shows a revenue of 796 million yuan, representing a year-on-year decrease of 16.49%, and a net profit of 25.6519 million yuan, down 9.35% year-on-year [1] - The gross profit margin for the company stands at 27.96% [1]